medline.ch Urologie-Nephrologie Tumoren BPH

	Predicting prostate cancer recurrence using an atlas-based tumor control probability model. Med Phys Mahtaba KR, Ebert MA, Booth J, Moghaddasi L, Finnegan R, Zhao Y, Javed B, Hruby G, Haworth A. PMID: 41532361 [PubMed - indexed for MEDLINE]
	RapidArc dynamic versus RapidArc: A multi anatomical-site dosimetric evaluation. J Appl Clin Med Phys Rostami A, Naim C, Sukumaran RP, Usman M, Mkanna AY, Al-Sabahi AF, Basith A, Chuck S, Barzegar M, Peltier BO, Aklan B, Baradaran S, Paloor SP, Hammoud RW. PMID: 41532265 [PubMed - indexed for MEDLINE]
	Translational Advances in Urothelial Carcinoma: From Bench to Bedside. Int J Urol Iwasawa T, Tsujino T, Tsukahara S, Fukushima H, Ito D, Tomiyama E, Urabe F, Japanese Young Urologist Basic Research Collaboration. PMID: 41531330 [PubMed - indexed for MEDLINE]
	Genitourinary Toxicity, Function, and Quality of Life in Patients Undergoing Prostate Radiation Therapy-A ScopingÂ Review. Low Urin Tract Symptoms Vrij C, Heesakkers J, Van Limbergen EJ, Palmgren JE, Leers M, de Jong M, Oerlemans D, Bruins HM, Marcellissen T, Rademakers K, de Vries P, Driessen EJM, van Osch F, van den Berkmortel F, van Roermund J, Hermans T. PMID: 41531161 [PubMed - indexed for MEDLINE]
	Radiomics and Image-based Artificial Intelligence for Predicting Recurrence and Survival After Surgery in Localized Renal Cell Carcinoma: An APPRAISE-AI Systematic Review and Meta-analysis. Eur Urol Focus Mjaess G, Diamand R, Dikete N, Kwong JCC, Pezzullo M, Margue G, Pasoglou V, Michoux N, Campi R, Amparore D, Aoun F, Albisinni S, Haroun P, Van Damme J, Peltier A, Bernhard JC, Zlotta AR, Tombal B, Quackels T, Roumeguère T. PMID: 41530034 [PubMed - as supplied by publisher]
	Re: Oscar Buisan, Pol Servian, Sonia PedreÃ±o-Lopez, et al. A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-GuÃ©rin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.014. Eur Urol Herr H. PMID: 41529977 [PubMed - as supplied by publisher]
	2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancer. Int J Radiat Oncol Biol Phys Yasar B, Suh YE, Chapman E, Nicholls L, Henderson D, Jones C, Morrison K, Wells E, Henderson J, Meehan C, Sohaib A, Taylor H, Tree A, van As N. PMID: 41529792 [PubMed - as supplied by publisher]
	An App-Based Behavioral Support Intervention Promoting Physical Activity (APPROACH) in Patients Diagnosed With Breast, Prostate, or Colorectal Cancer: Protocol for a Randomized Controlled Trial. JMIR Res Protoc Kennedy F, Smith SL, Beeken RJ, Buck C, Shearsmith L, Truscott H, Counsell N, Thomas C, Roberts A, Greenfield DM, Potts HW, Latimer N, Lowther E, Smith L, Stevens R, Creaser A, Gath J, Wyld L, Fisher A, Lally P. PMID: 41529252 [PubMed - indexed for MEDLINE]
	Association Between Sociodemographic Marginalization and Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer: Population-Based Cohort Study in Ontario, Canada. JCO Oncol Pract Nguyen DD, Satkunasivam R, Aminoltejari K, Hird A, Roy S, Morgan SC, Shayegan B, Kulkarni GS, Trinh QD, Rosella LC, Breau RH, Lalani AA, Wallis CJD. PMID: 41529225 [PubMed - as supplied by publisher]
	TESTOSTERONE DOES NOT DRIVE PROSTATE CANCER: PRESENTING THE NEW FRAMEWORK OF ANDROGEN ADEQUACY VERSUS INADEQUACY. J Urol Morgentaler A, Traish AM. PMID: 41529181 [PubMed - as supplied by publisher]
	Comparison of Oncologic and Functional Outcomes of Orifice Resection via Monopolar and Bipolar System in Bladder Tumors with Orifice Involvement. Urol Int Topcu YK, Yarimoglu S, Sefik E, Celik S, Bolat D, Bozkurt IH, Gunlusoy B, Degirmenci T. PMID: 41528962 [PubMed - as supplied by publisher]
	Trends in hypofractionated radiotherapy use among patients with breast or prostate cancer: a multicenter study in Osaka, Japan. J Radiat Res Ikawa T, Morishima T, Nakata K, Kuwabara Y, Kishimoto K, Kanayama N, Morimoto M, Konishi K, Miyashiro I. PMID: 41528887 [PubMed - as supplied by publisher]
	MRI-guided neurovascular bundle avoidance in high dose rate prostate brachytherapy. Brachytherapy Gerber DG, Dresser S, Yang X, Qiu RLJ, Jiang X, Desai S, Harms J, Patel SA, Hershatter B, Sebastian N, Dhere V, Liu T, Jani AB, Patel PR. PMID: 41528861 [PubMed - indexed for MEDLINE]
	Air Pollution, Lifestyle, and Genetic Risk: A Multidimensional Study of PM(2.5) Constituents and Prostate Cancer. J Urol Zhang F, Zhou J, Yang C, Wei S, Ma J. PMID: 41528828 [PubMed - as supplied by publisher]
	Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma. Discov Oncol Pang X, Wang Y, Zhang Q, Gu L. PMID: 41528614 [PubMed - as supplied by publisher]
	TMPRSS2 rs12329760 variant as a prognostic marker for prostate cancer progression. Mol Biol Rep Elghazali K, Najih M, Sakhi Z, Ennaji Y, Laaraqui A, Tagajdid R, Amine A, Ennaji MM. PMID: 41528570 [PubMed - indexed for MEDLINE]
	Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004). World J Urol Mjaess G, Quackels T, Fantoni JC, Tricard T, Marcq G, Blanc J, Barthelemy P, Carnot A, Sideris S, Awada A, Chanza NM, Peltier A, Albisinni S, Diamand R, Roumeguère T. PMID: 41528535 [PubMed - indexed for MEDLINE]
	Retroperitoneal lymph node dissection for growing teratoma syndrome in testicular cancer: a systematic review of surgical outcomes. World J Urol Costa Silva A, Morgado A, Alturas Silva J, Oliveira P, Clarke N, Almeida Pinto R, Gulamhusein A. PMID: 41528533 [PubMed - in process]
	Repeat transurethral resection and contemporary oncologic outcomes among patients with non-muscle invasive urothelial carcinoma of the bladder. World J Urol Perez-Londoño A, Kaul S, Fleishman A, Korets R, Rayala H, Chang P, Wagner AA, Bellmunt J, Olumi AF, Gershman B. PMID: 41528510 [PubMed - indexed for MEDLINE]
	A current profile of digital health literacy: patients undergoing holmium laser enucleation of the prostate (HoLEP). Different outcomes with population variation. A new prospective study. Aging Male Co, Mert MS, Akyol YK, Can U, Çanakçi C, Di. PMID: 41527383 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 184645

Seite 1 von 9233



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung